Table of Contents Table of Contents
Previous Page  746 / 1161 Next Page
Information
Show Menu
Previous Page 746 / 1161 Next Page
Page Background

1. MRI for targeting: prostate

Prostate cancer treatment

Boosting dominant intraprostatic lesions (DILs) in the

context of stereotactic ablative radiation therapy (SABR)

T2-weighted, dynamic contrast-enhanced and diffusion-

weighted magnetic resonance imaging

Prostate planning target volume (PTV) prescription: 42.7

Gy in 7 fractions (6.1 Gy/fr)

Median PTV

DIL

prescription: 125% (range: 110%-140%)

LJ Murray et al. Prostate Stereotactic Ablative Radiation Therapy Using

Volumetric Modulated Arc Therapy to Dominant Intraprostatic Lesions.

Int J Radiation Oncol Biol Phys, Vol. 89, No. 2, pp. 406e415, 2014